$LH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LABORATORY CORP OF AMERICA HOLDINGS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LABORATORY CORP OF AMERICA HOLDINGS. Get notifications about new insider transactions in LABORATORY CORP OF AMERICA HOLDINGS for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 37 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 11 2019 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | M | 0.00 | 297 | 0 | 1,517 | |
Feb 11 2019 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Payment of Exercise | F | 147.46 | 82 | 12,092 | 28,277 | 28.4 K to 28.3 K (-0.29 %) |
Feb 11 2019 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Buy | M | 0.00 | 297 | 0 | 28,359 | 28.1 K to 28.4 K (+1.06 %) |
Feb 11 2019 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | M | 0.00 | 247 | 0 | 1,287 | |
Feb 11 2019 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Payment of Exercise | F | 147.46 | 68 | 10,027 | 9,444 | 9.5 K to 9.4 K (-0.71 %) |
Feb 11 2019 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Buy | M | 0.00 | 247 | 0 | 9,512 | 9.3 K to 9.5 K (+2.67 %) |
Feb 11 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | M | 0.00 | 327 | 0 | 1,701 | |
Feb 11 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Payment of Exercise | F | 147.46 | 148 | 21,824 | 3,972 | 4.1 K to 4 K (-3.59 %) |
Feb 11 2019 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Buy | M | 0.00 | 327 | 0 | 4,120 | 3.8 K to 4.1 K (+8.62 %) |
Feb 11 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 297 | 0 | 4,494 | |
Feb 11 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 147.46 | 104 | 15,336 | 6,133 | 6.2 K to 6.1 K (-1.67 %) |
Feb 11 2019 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 297 | 0 | 6,237 | 5.9 K to 6.2 K (+5.00 %) |
Dec 07 2018 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Option Exercise | A | 0.00 | 3,174 | 0 | 4,212 | |
Nov 29 2018 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Sell | S | 162.14 | 350 | 56,749 | 7,886 | 8.2 K to 7.9 K (-4.25 %) |
Nov 07 2018 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | M | 64.42 | 3,700 | 238,354 | 0 | |
Nov 07 2018 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Sell | S | 163.29 | 3,700 | 604,162 | 18,095 | 21.8 K to 18.1 K (-16.98 %) |
Nov 07 2018 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Buy | M | 64.42 | 3,700 | 238,354 | 21,795 | 18.1 K to 21.8 K (+20.45 %) |
Sep 06 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Option Exercise | M | 0.00 | 153 | 0 | 11,068 | |
Sep 06 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Payment of Exercise | F | 169.15 | 69 | 11,671 | 1,850 | 1.9 K to 1.9 K (-3.60 %) |
Sep 06 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Buy | M | 0.00 | 153 | 0 | 1,919 | 1.8 K to 1.9 K (+8.66 %) |
Aug 15 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Gift | G | 0.00 | 695 | 0 | 219,711 | 220.4 K to 219.7 K (-0.32 %) |
Aug 15 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Gift | G | 0.00 | 1,389 | 0 | 220,406 | 221.8 K to 220.4 K (-0.63 %) |
Jun 08 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | M | 84.86 | 13,000 | 1,103,180 | 0 | |
Jun 08 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Sell | S | 183.35 | 13,000 | 2,383,558 | 9,113 | 22.1 K to 9.1 K (-58.79 %) |
Jun 08 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Buy | M | 84.86 | 13,000 | 1,103,180 | 22,113 | 9.1 K to 22.1 K (+142.65 %) |
Jun 06 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Sell | S | 182.10 | 4,500 | 819,451 | 3,755 | 8.3 K to 3.8 K (-54.51 %) |
Jun 04 2018 | LH | LABORATORY CORP OF ... | Gilliland Dwight Gary | Director | Sell | S | 181.30 | 400 | 72,520 | 3,501 | 3.9 K to 3.5 K (-10.25 %) |
Jun 04 2018 | LH | LABORATORY CORP OF ... | Gilliland Dwight Gary | Director | Sell | S | 181.29 | 300 | 54,387 | 3,901 | 4.2 K to 3.9 K (-7.14 %) |
Jun 04 2018 | LH | LABORATORY CORP OF ... | Gilliland Dwight Gary | Director | Sell | S | 181.29 | 436 | 79,040 | 4,201 | 4.6 K to 4.2 K (-9.40 %) |
Jun 04 2018 | LH | LABORATORY CORP OF ... | Gilliland Dwight Gary | Director | Sell | S | 181.26 | 127 | 23,020 | 4,637 | 4.8 K to 4.6 K (-2.67 %) |
Jun 04 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Sell | S | 182.37 | 315 | 57,447 | 5,940 | 6.3 K to 5.9 K (-5.04 %) |
Jun 04 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Sell | S | 182.30 | 5,185 | 945,226 | 6,255 | 11.4 K to 6.3 K (-45.32 %) |
Jun 01 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Sell | S | 182.50 | 1,610 | 293,823 | 1,610 | 3.2 K to 1.6 K (-50.00 %) |
Jun 01 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Sell | S | 181.50 | 3,280 | 595,316 | 15,563 | 18.8 K to 15.6 K (-17.41 %) |
Jun 01 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Sell | S | 181.06 | 6,720 | 1,216,749 | 18,843 | 25.6 K to 18.8 K (-26.29 %) |
May 25 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 84.86 | 49,966 | 4,240,115 | 0 | |
May 25 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 176.13 | 5,400 | 951,092 | 221,669 | 227.1 K to 221.7 K (-2.38 %) |
May 25 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 175.27 | 44,566 | 7,811,252 | 227,069 | 271.6 K to 227.1 K (-16.41 %) |
May 25 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 84.86 | 49,966 | 4,240,115 | 271,635 | 221.7 K to 271.6 K (+22.54 %) |
Apr 25 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 84.86 | 49,967 | 4,240,200 | 49,966 | |
Apr 25 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 166.37 | 21,200 | 3,526,985 | 221,669 | 242.9 K to 221.7 K (-8.73 %) |
Apr 25 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 165.94 | 28,767 | 4,773,711 | 242,869 | 271.6 K to 242.9 K (-10.59 %) |
Apr 25 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 84.86 | 49,967 | 4,240,200 | 271,636 | 221.7 K to 271.6 K (+22.54 %) |
Apr 06 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Option Exercise | M | 0.00 | 3,500 | 0 | 11,221 | |
Apr 06 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Option Exercise | M | 0.00 | 3,500 | 0 | 11,221 | |
Apr 06 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Payment of Exercise | F | 163.84 | 1,376 | 225,444 | 3,220 | 4.6 K to 3.2 K (-29.94 %) |
Apr 06 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Payment of Exercise | F | 163.84 | 1,376 | 225,444 | 3,220 | 4.6 K to 3.2 K (-29.94 %) |
Apr 06 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Buy | M | 0.00 | 3,500 | 0 | 4,596 | 1.1 K to 4.6 K (+319.34 %) |
Apr 06 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Buy | M | 0.00 | 3,500 | 0 | 4,596 | 1.1 K to 4.6 K (+319.34 %) |
Apr 05 2018 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | A | 0.00 | 12,120 | 0 | 26,337 | |
Apr 02 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 161.75 | 2,121 | 343,072 | 11,440 | 13.6 K to 11.4 K (-15.64 %) |
Apr 02 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Grant | A | 0.00 | 4,852 | 0 | 13,561 | 8.7 K to 13.6 K (+55.71 %) |
Apr 02 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Payment of Exercise | F | 161.75 | 1,600 | 258,800 | 9,113 | 10.7 K to 9.1 K (-14.94 %) |
Apr 02 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Grant | A | 0.00 | 4,852 | 0 | 10,713 | 5.9 K to 10.7 K (+82.78 %) |
Apr 02 2018 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Payment of Exercise | F | 161.75 | 2,152 | 348,086 | 28,062 | 30.2 K to 28.1 K (-7.12 %) |
Apr 02 2018 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Grant | A | 0.00 | 5,595 | 0 | 30,214 | 24.6 K to 30.2 K (+22.73 %) |
Apr 02 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 161.75 | 8,850 | 1,431,488 | 25,563 | 34.4 K to 25.6 K (-25.72 %) |
Apr 02 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Grant | A | 0.00 | 19,687 | 0 | 34,413 | 14.7 K to 34.4 K (+133.69 %) |
Apr 02 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 161.75 | 33,015 | 5,340,176 | 221,669 | 254.7 K to 221.7 K (-12.96 %) |
Apr 02 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Grant | A | 0.00 | 73,449 | 0 | 254,684 | 181.2 K to 254.7 K (+40.53 %) |
Apr 02 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Payment of Exercise | F | 161.75 | 2,828 | 457,429 | 8,255 | 11.1 K to 8.3 K (-25.52 %) |
Apr 02 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Grant | A | 0.00 | 6,493 | 0 | 11,083 | 4.6 K to 11.1 K (+141.46 %) |
Mar 27 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 84.86 | 49,967 | 4,240,200 | 99,933 | |
Mar 27 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 166.38 | 1,700 | 282,838 | 181,235 | 182.9 K to 181.2 K (-0.93 %) |
Mar 27 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 165.39 | 10,313 | 1,705,658 | 182,935 | 193.2 K to 182.9 K (-5.34 %) |
Mar 27 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 164.55 | 36,265 | 5,967,435 | 193,248 | 229.5 K to 193.2 K (-15.80 %) |
Mar 27 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Sell | S | 163.58 | 1,689 | 276,287 | 229,513 | 231.2 K to 229.5 K (-0.73 %) |
Mar 27 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 84.86 | 49,967 | 4,240,200 | 231,202 | 181.2 K to 231.2 K (+27.57 %) |
Mar 14 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | M | 0.00 | 400 | 0 | 1,534 | |
Mar 14 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Payment of Exercise | F | 175.61 | 111 | 19,493 | 5,861 | 6 K to 5.9 K (-1.86 %) |
Mar 14 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Buy | M | 0.00 | 400 | 0 | 5,972 | 5.6 K to 6 K (+7.18 %) |
Mar 14 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 6,077 | 0 | 26,524 | |
Mar 14 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 175.61 | 2,732 | 479,767 | 181,235 | 184 K to 181.2 K (-1.49 %) |
Mar 14 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 6,077 | 0 | 183,967 | 177.9 K to 184 K (+3.42 %) |
Mar 14 2018 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | M | 0.00 | 464 | 0 | 1,814 | |
Mar 14 2018 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Payment of Exercise | F | 175.61 | 129 | 22,654 | 24,619 | 24.7 K to 24.6 K (-0.52 %) |
Mar 14 2018 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Buy | M | 0.00 | 464 | 0 | 24,748 | 24.3 K to 24.7 K (+1.91 %) |
Mar 14 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,627 | 0 | 9,204 | |
Mar 14 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 175.61 | 732 | 128,547 | 14,726 | 15.5 K to 14.7 K (-4.74 %) |
Mar 14 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 1,627 | 0 | 15,458 | 13.8 K to 15.5 K (+11.76 %) |
Mar 14 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 400 | 0 | 4,791 | |
Mar 14 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 175.61 | 120 | 21,073 | 8,709 | 8.8 K to 8.7 K (-1.36 %) |
Mar 14 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 400 | 0 | 8,829 | 8.4 K to 8.8 K (+4.75 %) |
Mar 14 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | M | 0.00 | 537 | 0 | 2,028 | |
Mar 14 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Payment of Exercise | F | 175.61 | 184 | 32,312 | 4,590 | 4.8 K to 4.6 K (-3.85 %) |
Mar 14 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Buy | M | 0.00 | 537 | 0 | 4,774 | 4.2 K to 4.8 K (+12.67 %) |
Feb 14 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 168.49 | 41,000 | 6,908,090 | 41,000 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | A | 0.00 | 10,540 | 0 | 32,601 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | A | 0.00 | 2,340 | 0 | 10,831 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | A | 168.49 | 9,100 | 1,533,259 | 9,100 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Sell | S | 168.61 | 500 | 84,307 | 13,831 | 14.3 K to 13.8 K (-3.49 %) |
Feb 14 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Sell | S | 167.78 | 1,600 | 268,444 | 14,331 | 15.9 K to 14.3 K (-10.04 %) |
Feb 14 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Sell | S | 167.16 | 6,300 | 1,053,089 | 15,931 | 22.2 K to 15.9 K (-28.34 %) |
Feb 14 2018 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | A | 0.00 | 700 | 0 | 2,278 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | A | 168.49 | 2,700 | 454,923 | 2,700 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | A | 0.00 | 770 | 0 | 2,565 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | A | 168.49 | 3,000 | 505,470 | 3,000 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | A | 0.00 | 4,390 | 0 | 14,217 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | A | 168.49 | 17,100 | 2,881,179 | 17,100 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | A | 0.00 | 590 | 0 | 1,934 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | A | 168.49 | 2,300 | 387,527 | 2,300 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 0.00 | 700 | 0 | 5,191 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | A | 168.49 | 2,700 | 454,923 | 2,700 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Option Exercise | A | 0.00 | 1,760 | 0 | 14,721 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | Gary M. Huff | CEO, LabCorp Diagno ... | Option Exercise | A | 168.49 | 6,800 | 1,145,732 | 6,800 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | Williams R Sanders | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | Schechter Adam H | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | Parham Richelle P | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | NEUPERT PETER M | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | Kong Garheng | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | Gilliland Dwight Gary | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | BELINGARD JEAN-LUC | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
Feb 14 2018 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
Feb 13 2018 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 6,100 | 0 | 9,827 | |
Feb 13 2018 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Payment of Exercise | F | 168.08 | 2,132 | 358,347 | 9,398 | 11.5 K to 9.4 K (-18.49 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Buy | M | 0.00 | 6,100 | 0 | 11,530 | 5.4 K to 11.5 K (+112.34 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Option Exercise | M | 75.63 | 3,300 | 249,579 | 0 | |
Feb 13 2018 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Sell | S | 166.10 | 3,300 | 548,124 | 18,095 | 21.4 K to 18.1 K (-15.42 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | ANDERSON KERRII B | Director | Buy | M | 75.63 | 3,300 | 249,579 | 21,395 | 18.1 K to 21.4 K (+18.24 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,047 | 0 | 8,491 | |
Feb 13 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,830 | 0 | 11,538 | |
Feb 13 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 168.08 | 913 | 153,457 | 22,231 | 23.1 K to 22.2 K (-3.94 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 3,047 | 0 | 23,144 | 20.1 K to 23.1 K (+15.16 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Payment of Exercise | F | 168.08 | 549 | 92,276 | 20,097 | 20.6 K to 20.1 K (-2.66 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | EISENBERG GLENN A | Chief Financial Off ... | Buy | M | 0.00 | 1,830 | 0 | 20,646 | 18.8 K to 20.6 K (+9.73 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 3,047 | 0 | 4,491 | |
Feb 13 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Option Exercise | M | 0.00 | 450 | 0 | 7,538 | |
Feb 13 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 168.08 | 913 | 153,457 | 8,429 | 9.3 K to 8.4 K (-9.77 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 3,047 | 0 | 9,342 | 6.3 K to 9.3 K (+48.40 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Payment of Exercise | F | 168.08 | 135 | 22,691 | 6,295 | 6.4 K to 6.3 K (-2.10 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | BERBERIAN LANCE | SVP, Chief Informat ... | Buy | M | 0.00 | 450 | 0 | 6,430 | 6 K to 6.4 K (+7.53 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Option Exercise | M | 0.00 | 450 | 0 | 1,344 | |
Feb 13 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Payment of Exercise | F | 168.08 | 167 | 28,069 | 5,506 | 5.7 K to 5.5 K (-2.94 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | Dodson Edward T | Principal Accountin ... | Buy | M | 0.00 | 450 | 0 | 5,673 | 5.2 K to 5.7 K (+8.62 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Option Exercise | M | 0.00 | 520 | 0 | 1,578 | |
Feb 13 2018 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Payment of Exercise | F | 168.08 | 144 | 24,204 | 24,284 | 24.4 K to 24.3 K (-0.59 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | EBERTS F SAMUEL III | Chief Legal Officer ... | Buy | M | 0.00 | 520 | 0 | 24,428 | 23.9 K to 24.4 K (+2.18 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | M | 0.00 | 603 | 0 | 1,795 | |
Feb 13 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Payment of Exercise | F | 168.08 | 203 | 34,120 | 4,237 | 4.4 K to 4.2 K (-4.57 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Buy | M | 0.00 | 603 | 0 | 4,440 | 3.8 K to 4.4 K (+15.72 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 7,543 | 0 | 22,061 | |
Feb 13 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 168.08 | 3,138 | 527,435 | 177,890 | 181 K to 177.9 K (-1.73 %) |
Feb 13 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 7,543 | 0 | 181,028 | 173.5 K to 181 K (+4.35 %) |
Feb 09 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Option Exercise | M | 0.00 | 326 | 0 | 2,398 | |
Feb 09 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Payment of Exercise | F | 169.66 | 129 | 21,886 | 3,837 | 4 K to 3.8 K (-3.25 %) |
Feb 09 2018 | LH | LABORATORY CORP OF ... | Uthgenannt Lisa J | Chief Human Resourc ... | Buy | M | 0.00 | 326 | 0 | 3,966 | 3.6 K to 4 K (+8.96 %) |
Feb 09 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Option Exercise | M | 0.00 | 4,220 | 0 | 29,604 | |
Feb 09 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Payment of Exercise | F | 169.66 | 1,264 | 214,450 | 173,485 | 174.7 K to 173.5 K (-0.72 %) |
Feb 09 2018 | LH | LABORATORY CORP OF ... | KING DAVID P | President & CEO | Buy | M | 0.00 | 4,220 | 0 | 174,749 | 170.5 K to 174.7 K (+2.47 %) |